XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.31

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (16755)	3/22/2004 3:01:23 PM
From: Cacaito	Read Replies (1) of 17367

Zoooospecific that it does not works in the joints. Zoooospecific that the platelets (Do you remember people needs platelets!!!) go down the tubes! PDLI keep its royalties, from even the tiniest product indication in any of their drugs. Tanox fought with teeth and nails against Dna and Roche, for their royalties. xoma sold 5% Rituxan for $18M stinky ones to finance WREACKAGE search, they CAUSED WREACKAGE, of course they can find it!!! They should sell the carcass to Pdli. Dna could now buy their sospecific drug for $1 I could not believe that sub$1 will come after approval, I always said $4, but under $1 is coming.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next